About
Modulate Bio develops novel small molecule positive allosteric modulators of the GABA A receptor to treat neurological disorders such as Essential Tremor, epilepsy, and anxiety.
Explore Modulate Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.